As of the end of the quarter Eqis Capital Management, Inc. had acquired 390 shares growing its stake by 1.8%. Moreover, Cincinnati Specialty Underwriters Company has 3.85% invested in BlackRock, Inc.
Analysts often look at short interest, or the number of shares now being shorted by investors, to aid in their outlook for a particular stock. It has outperformed by 0.76% the S&P500.
Cohen Capital Management, Inc. decreased its stake in JP Morgan Chase & Co.by 1.3% as reported in a filing on 10/11/2017. Mufg Americas Holdings Corp sold 6,046 shares as Jpmorgan Chase & Co (JPM)'s stock declined 6.04%. It dived, as 28 investors sold RYN shares while 64 reduced holdings. Pacific Center for Financial Services grew its holdings in shares of J P Morgan Chase & Co by 14.5% during the first quarter.
The share price of J P Morgan Chase & Co (NYSE:JPM) was up +0.75% during the last trading session, with a day high of 97.18. About shares traded. Rayonier Inc. Proteon Therapeutics Inc (NASDAQ:PRTO) has declined 80.63% since October 11, 2016 and is downtrending.
Investors sentiment increased to 1.19 in Q2 2017. Its up 0.32, from 0.87 in 2017Q1. Gradient Investments LLC raised its stake in J P Morgan Chase & Co by 9.1% in the 2nd quarter. Also, General Counsel Stacey Friedman sold 9,968 shares of the business's stock in a transaction dated Monday, August 21st. Illinois-based Duff & Phelps Inv has invested 0.01% in BlackRock, Inc. Edgar Lomax Va reported 1.5% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Schmidt P J invested 0.06% in JPMorgan Chase & Co. (NYSE:JPM). Pennsylvania Tru Comm stated it has 329,697 shares or 1.49% of all its holdings. Over the course of the past year JPM has set a 52-week high of $97.64 while the corresponding low set was $66.74. (NYSE:JPM). Savant Capital Lc invested in 0.51% or 23,708 shares. Thomaspartners Inc. now owns 2,572,428 shares of the financial services provider's stock valued at $225,962,000 after acquiring an additional 70,882 shares during the period.
Total debt to equity ratio of the company for most recent quarter is 1.26 while Long term debt to equity ratio for same time period is 1.26.
06/02/2017 - J P Morgan Chase & Co had its "neutral" rating reiterated by analysts at Instinet. Tower Research Ltd Limited Liability Company (Trc) has 0% invested in Proteon Therapeutics Inc (NASDAQ:PRTO). Comparatively, JPMorgan Chase & Co. posted earnings of $1.54 per share in the same quarter a year ago. (NYSE:JPM). Whitnell holds 0.31% in JPMorgan Chase & Co. The share last price represents downtick move of -1.26% in value from company's 52-Week high price and shows 44.47% above change in value from its 52-Week low price. The expected JPM's profit could reach $5.95B giving the stock 14.37 P/E in the case that $1.69 earnings per share is reported. The financial services provider reported $1.65 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.52 by $0.13.
Since May 11, 2017, it had 0 insider buys, and 1 insider sale for $568,100 activity. Cypress Asset Tx has invested 2.73% in JPMorgan Chase & Co. Therefore 52% are positive. Rayonier had 19 analyst reports since August 6, 2015 according to SRatingsIntel. On Friday, July 7 the stock rating was maintained by Jefferies with "Buy". (NYSE:JPM) rating on Thursday, April 14. Deutsche Bank downgraded the shares of JPM in report on Tuesday, September 26 to "Hold" rating. Bank of America Corporation restated an "outperform" rating and set a $99.00 target price on shares of J P Morgan Chase & Co in a report on Wednesday, June 21st. (NYSE:JPM) has risen 33.74% since October 11, 2016 and is uptrending. (NYSE:JPM) has "Buy" rating given on Tuesday, June 6 by Jefferies. Argus Research maintained JPMorgan Chase & Co. (JPM) stock was most active stock of Wall Street Market on Monday. The stock has "Outperform" rating by Credit Agricole on Tuesday, August 25. The shares were sold at an average price of $91.29, for a total value of $91,290.00. Schwab Strategic Tr (SCHV) was raised too.
Investors sentiment increased to 1.19 in 2017 Q2. Its up 1.43, from 0.69 in 2017Q1. 12 funds opened positions while 24 raised stakes. Bnp Paribas Arbitrage Sa has 0% invested in Allied Motion Technologies, Inc. Goelzer Investment Mngmt accumulated 43,162 shares or 0.48% of the stock. Lombard Odier Asset (Europe) Limited invested in 0.02% or 1,297 shares. Trustco Bancorporation N Y has 36,513 shares for 3.3% of their portfolio. Bancorporation Of Mellon Corporation holds 0% or 129,434 shares. Tocqueville Asset Ltd Partnership holds 0.25% or 230,668 shares in its portfolio. (NYSE:RYN) for 120,696 shares. Nationwide Fund Advsr reported 0.92% stake. State Of Tennessee Treasury Department holds 0.02% of its portfolio in Rayonier Inc. Morgan Stanley reported 317 shares.
Analysts await BlackRock, Inc. The firm earned "Neutral" rating on Monday, January 11 by Goldman Sachs. Therefore 29% are positive. (The) reiterated a "neutral" rating and set a $93.00 price objective on shares of J P Morgan Chase & Co in a report on Thursday, July 6th.